Is a complete BHVN research report available?

No complete published report is available for Biohaven Ltd. (BHVN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Biohaven Ltd. (BHVN)

NYSE: BHVN · USD

$14.3

-0.33 (-2.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BHVN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.2B
Net income (ttm)	-647.7M
EPS (ttm)	-$5.44
Shares out	150.6M
Volume	1,718,080
Beta	3.14
Price target	$22.8	+58.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -647.7M
EPS (ttm): -$5.44
Market cap: 2.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BHVN indicators

Market & fundamental data

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001935979
Company name	Biohaven Ltd.
Country	United States
Country code	US
Cusip	G1110E107
Employees	274
Employees Change	18%
Employees Change Percent	7.03
Enterprise value	$2.1B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2017-05-04
Isin	VGG1110E1079
Last refreshed	2026-07-25
Market cap	$2.2B
Market cap category	Mid-Cap
Price	$14.32
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	BHVN
Website	https://www.biohaven.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-30.04%
FCF yield	-27.57%
P/B ratio	16.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-647.7M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Profit Per Employee	$-2.4M
ROA	-83.38
Roa5y	-84.74
ROCE	-157.9
ROE	-333
Roe5y	-204.7
ROIC	-108.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	4.22%
Cagr3y	-17.43%
EPS Growth Quarters	6
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$466.4M
Cash	$347.8M
Current Assets	$385.6M
Current Liabilities	$52.1M
Debt	$286.2M
Debt Equity	$2.21
Equity	$129.5M
Liabilities	$336.9M
Long Term Assets	$80.8M
Long Term Liabilities	$284.8M
Net Cash	$61.6M
Net Cash By Market Cap	$2.86
Net Cash Growth	-78.54%
Net Debt Equity	$-0.48
Tangible Book Value	$109.7M
Tangible Book Value Per Share	$0.73
WACC	18.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.41
Net Working Capital	$-8.3M
Quick ratio	6.68
Working Capital	$333.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-23.59%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	4.22%
200-day SMA	11.63
3Y total return	-43.71%
50-day SMA	12.86
50-day SMA vs 200-day SMA	50over200
All Time High	62.21
All Time High Change	-76.98%
All Time High Date	2024-03-08
All Time Low	5.54
All Time Low Change	158.48%
All Time Low Date	2022-10-03
ATR	1
Beta	3.14
Beta1y	1.51
Beta2y	1.54
Ch YTD	26.84
High	14.98
High52	18.57
High52 Date	2025-10-30
High52ch	-22.87%
Low	13.88
Low52	7.48
Low52 Date	2025-11-11
Low52ch	91.44%
Ma50ch	11.32%
Price vs 200-day SMA	23.1%
RSI	48.88
RSI Monthly	45.24
RSI Weekly	58.38
Sharpe ratio	0.48x
Sortino ratio	0.77
Total Return	-23.59%
Tr YTD	26.84
Tr1m	-3.11%
Tr1w	-7.25%
Tr3m	36.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	18
Analyst Count Top	11
Analyst Price Target Top	$20.78
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.64
Operating Income	$-617.2M
Price target	$22.75
Price Target Change	$58.87
Price Target Change Top	$45.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	123,750,786%
Float Percent	82.19%
Net Borrowing	250,000,000
Shares Insiders	10.97%
Shares Institutions	83.13%
Shares Out	150,560,990
Shares Qo Q	22.82%
Shares Yo Y	23.59%
Short Float	16.54%
Short Ratio	5.15
Short Shares	13.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-682.1M
Average Volume	2,763,026.1x
Bv Per Share	0.86
CAPEX	$-254,000
Ch1m	-3.11
Ch1w	-7.25
Ch1y	4.22
Ch3m	36.12
Ch3y	-43.71
Ch6m	6
Change	-2.25%
Change From Open	-2.45
Close	14.65
Days Gap	0.2
Depreciation Amortization	10,042,000
Dollar Volume	24,602,905.6
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-654.2M
EBITDA	$-644.2M
EPS	$-5.44
F Score	2
FCF	$-594.5M
FCF EV Yield	-28.38x
FCF Per Share	$-3.95
Financing CF	617,764,000
Fiscal Year End	December
Founded	2,013
Goodwill	1,390,000
Income Tax	$1.1M
Investing CF	150,894,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	11.38
Ma150ch	25.87%
Ma20	15.33
Ma20ch	-6.6%
Net CF	174,416,000
Next Earnings Date	2026-08-07
Open	14.68
Optionable	Yes
Position In Range	40
Post Close	14.32
Postmarket Change Percent	-1.4
Postmarket Price	$14.12
Ppne	58,656,000
Price Date	2026-07-24
Ptbv Ratio	19.65
Relative Volume	0.62x
Share Based Comp	87,585,000
Tr6m	6%
Us State	Connecticut
Volume	1,718,080

Biohaven Ltd. (BHVN)

Coverage state: Market snapshot only — no published research

Generate the first BHVN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BHVN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BHVN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BHVN

Frequently asked questions